Skip to content

Clinical trials

Hypertension, Pulmonary trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: China Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20072
20084
20096
20102
20111
20122
20133
20142
20153
20174
20183
20194
20204
20212
20223
20236
20246
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting19
Unknown status14
Active, not recruiting5
Terminated4
Not yet recruiting3
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Chinese Academy of Medical Sciences, Fuwai Hospital5
Chinese Pulmonary Vascular Disease Research Group5
Actelion4
China National Center for Cardiovascular Diseases4
Shanghai Jiao Tong University School of Medicine4
United Therapeutics4
Pfizer3
RenJi Hospital3
China-Japan Friendship Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary75
Pulmonary Arterial Hypertension21
Heart Failure9
Cardiovascular Diseases6
Disease5
Vascular Diseases5
Hypertension4
Pulmonary Disease, Chronic Obstructive4
Lung Diseases3
Bronchiectasis2

Trials

Showing 76 to 75 of 75. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.